A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse

Clinical trial NCT01952223 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01952223
Sponsor: UNICANCER
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Adenocarcinoma of Prostate Progression of Prostate Cancer

Start date: 2013-12-01
Primary completion: 2025-12-01
Enrollment: 761

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.